Eptifibatide fumarate, marketed under the brand name Integrilin, represents a valuable intervention within cardiology. This antiplatelet agent functions as a glycoprotein IIb/IIIa receptor antagonist, effectively https://mediajx.com/story27432246/eptifibatide-fumarate